Clinical Trials and Translational Research Advisory Committee (CTAC) Members
Members of the Clinical Trials and Translational Research Advisory Committee (CTAC), appointed by the NCI Director, make recommendations on the NCI-supported national clinical trials enterprise.
Chair
Julie M. Vose, M.D. (2025)
Neumann M. and Mildred E. Harris Professor
Chief, Division of Hematology/Oncology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska
Members
Nilofer S. Azad, M.D. (2026)
Professor of Oncology
Co-Director, Developmental Therapeutics Group
Co-Leader, Cancer Genetics and Epigenetics Program
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland
Smita Bhatia M.D., M.P.H. (2025)
Vice Chair of Outcomes for Pediatrics
Professor
Division of Hematology/Oncology
Department of Pediatrics
University of Alabama at Birmingham
Birmingham, Alabama
Charles D. Blanke, M.D. (2025)
Chair, SWOG Cancer Research Network
Professor
Knight Cancer Institute
Oregon Health and Sciences University
Portland, Oregon
Adam P. Dicker, M.D., Ph.D. (2025)
Professor and Chair
Department of Radiation Oncology
Sidney Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, Pennsylvania
Gary C. Doolittle, M.D. (2026)
Capitol Federal Masonic Professor
Division of Medical Oncology
University of Kansas Medical Center
Westwood, Kansas
Ernest T. Hawk, M.D. (2025)
Vice President and Head
Division of Cancer Prevention and Population Sciences
T. Boone Pickens Distinguished Chair for Early Prevention of Cancer
The University of Texas MD Anderson Cancer Center
Houston, Texas
Ken Kobayashi, M.D., F.A.C.P. (2028)
Chief Medical Officer
Pyxis Oncology
Boston, Massachusetts
Seth P. Lerner, M.D., F.A.C.S. (2025)
SWOG GU Committee Chair
Vice Chair for Faculty Affairs
Beth and Dave Swalm Chair in Urologic Oncology
Professor
Scott Department of Urology
Baylor College of Medicine
Houston, Texas
Sumithra J. Mandrekar, Ph.D. (2025)
Professor of Biostatistics
Group Statistician, Alliance for Clinical Trials in Oncology
Department of Quantitative Health Sciences
Mayo Clinic College of Medicine
Rochester, Minnesota
Robert S. Mannel, M.D. (2026)
Director
Peggy and Charles Stephenson Cancer Center
College of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Ruben A. Mesa, M.D. (2026)
President, Enterprise Cancer Service Line Atrium Health
Executive Director, Atrium Health Wake Forest
Baptist Comprehensive Cancer Center
Senior Vice President, Atrium Health
Vice Dean for Cancer Programs
Wake Forest School of Medicine
Winston-Salem, North Carolina
Carolyn Y. Muller, M.D., F.A.C.O.G. (2025)
Associate Director of Clinical Research
The Judy Putman Dirks Endowed Professor in Gynecologic Cancer Care
Department of Obstetrics and Gynecology
The University of New Mexico Health Sciences Center
Albuquerque, New Mexico
Raphael E. Pollock, M.D., Ph.D., F.A.C.S. (2025)
Kathleen Wellenreiter Klotz Chair in Cancer Research
Director
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Suresh S. Ramalingam, M.D., F.A.S.C.O. (2025)
Professor
Winship Cancer Institute
Roberto C. Goizueta Chair for Cancer Research
Emory University School of Medicine
Atlanta, Georgia
Victor M. Santana, M.D. (2025)
Director for Global Research Operations
St. Jude Children's Research Hospital
Memphis, Tennessee
Patricia A. Spears (2026)
Scientific Research Manager
Patient Advocate
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
George Wilding, M.D. (2026)
Professor Emeritus and Director Emeritus
University of Wisconsin, Madison
Albuquerque, New Mexico
Ex Officio Members
Michael J. Kelley, M.D., F.A.C.P.
National Program Director for Oncology
Veterans Health Administration
Department of Veterans Affairs
Durham, North Carolina
Richard Pazdur, M.D., F.A.C.P.
Director
Oncology Center of Excellence
U.S. Food and Drug Administration
Silver Spring, Maryland
TBN
Center for Medicare and Medicaid Services
Baltimore, Maryland
Designated Federal Official
Sheila A. Prindiville, M.D., M.P.H.
Director
Coordinating Center for Clinical Trials
Office of the Director
National Cancer Institute
National Institutes of Health
Bethesda, Maryland